Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.
View Top Employees from ZentivaWebsite | http://www.zentiva.com |
Ticker | LSE:0I6N |
Revenue | $111 million |
Employees | 3,289 (2,183 on RocketReach) |
Founded | 1488 |
Address | 529/16 U Kabelovny, Prague, Praha 102 00, CZ |
Phone | 42267241111 |
Technologies |
JavaScript,
HTML,
Twitter
+92 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Manufacturing, Drug Delivery, Generics, Healthcare, Pharmaceutical, Health Care |
Web Rank | 1 Million |
Keywords | Generic Drugs |
Competitors | Angelini Pharma, Bosnalijek JSC, Par Pharmaceutical, Pharma Science Inc, Sun Farmaceutica do Brasil |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 44 Companies, NAICS Code 45 Companies |
Looking for a particular Zentiva employee's phone or email?
The Zentiva annual revenue was $111 million in 2024.
Martin Albert is the Chief Scientific Officer of Zentiva.
2,183 people are employed at Zentiva.
Zentiva is based in Prague, Praha.
The NAICS codes for Zentiva are [44, 45].
The SIC codes for Zentiva are [283, 28].